Cargando…
Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight)
BACKGROUND: The use of prescription anti-obesity medication (AOM) is becoming increasingly common as treatment options grow and become more accessible. However, AOM may not be without a wide range of potentially negative impacts on patient functioning and well being. The Treatment Related Impact Mea...
Autores principales: | Brod, Meryl, Hammer, Mette, Kragh, Nana, Lessard, Suzanne, Bushnell, Donald M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841109/ https://www.ncbi.nlm.nih.gov/pubmed/20137088 http://dx.doi.org/10.1186/1477-7525-8-19 |
Ejemplares similares
-
Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device)
por: Brod, Meryl, et al.
Publicado: (2009) -
Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures
por: Brod, Meryl, et al.
Publicado: (2011) -
Development of the Weight-Related Sign and Symptom Measure
por: Brod, Meryl, et al.
Publicado: (2018) -
Assessing the Impact of Growth Hormone Deficiency (GHD) in Adults: Interpreting Change of the Treatment-Related Impact Measure—Adult Growth Hormone Deficiency (TRIM-AGHD)
por: Brod, Meryl, et al.
Publicado: (2018) -
Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM)
por: Brod, Meryl, et al.
Publicado: (2021)